mda-mb-468 glutathione content Xenograft Model Natural product preferentially targets redox
Natural product preferentially targets redox and metabolic adaptations and aberrantly active STAT3 to inhibit breast tumor growth in vivo Cell Death & Disease Using a novel panel of drug resistant triple negative breast cancer cell lines to identify candidate therapeutic targets and biomarkers ScienceDirect MDA MB 468 Luciferase Reporter Cell Line AcceGen The oncoprotein MUC1 facilitates breast cancer progression by promoting Pink1 dependent mitophagy via ATAD3A destabilization Cell Death & Disease
Pay in 4 interest-free payments of $5.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



